v3.26.1
Share-Based Payment Arrangements - Schedule of Expenses Recognized in the Consolidated Financial Statements (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Schedule of Expenses Recognized in the Consolidated Financial Statements [Line Items]      
Total share-based expense recognized $ 309 $ 582 $ 1,875
Research and development expenses [Member]      
Schedule of Expenses Recognized in the Consolidated Financial Statements [Line Items]      
Total share-based expense recognized 113 117 768
Selling, general and administrative expense [member]      
Schedule of Expenses Recognized in the Consolidated Financial Statements [Line Items]      
Total share-based expense recognized $ 196 $ 465 $ 1,107